Brain angiotensin-(1-7)/Mas axis: A new target to reduce the cardiovascular risk to emotional stress

Marco Antônio Peliky Fontes1, Augusto Martins Lima2, Robson Augusto Souza dos Santos3

  • 1National Institute of Science and Technology in Nanobiopharmaceutics (INCT - Nanobiofar), Department of Physiology and Biophysics, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.

Neuropeptides
|November 21, 2015
PubMed

Insights

Emotional stress contributes to cardiovascular diseases. The angiotensin-(1-7)/Mas axis, a counterregulatory system, shows promise in reducing stress responses and mitigating cardiac risks.

Area of Science:

  • Neuroendocrinology
  • Cardiovascular Physiology
  • Stress Response Mechanisms

Background:

  • Emotional stress is a recognized risk factor for cardiovascular diseases like arrhythmias and hypertension.
  • Neuroendocrine and autonomic mechanisms mediate the body's response to emotional stress.
  • The precise links between stress, cardiovascular health, and regulatory pathways require further elucidation.

Purpose of the Study:

  • To review the role of the renin-angiotensin system (RAS) in emotional stress responses.
  • To highlight the counterregulatory angiotensin-converting enzyme 2 (ACE2)/(Ang)iotensin-(1-7)/Mas axis.
  • To explore the therapeutic potential of the angiotensin-(1-7)/Mas axis in managing stress-related cardiovascular risks.

Main Methods:

  • Literature review of studies investigating the RAS and emotional stress.
  • Analysis of research on the ACE/angiotensin II/AT1 receptor axis in stress.
  • Examination of evidence supporting the anxiolytic and antihypertensive effects of the ACE2/(Ang)iotensin-(1-7)/Mas axis.

Main Results:

  • The ACE/angiotensin II/AT1 receptor axis is implicated in facilitating emotional stress responses.
  • The ACE2/(Ang)iotensin-(1-7)/Mas axis demonstrates anxiolytic properties.
  • This counterregulatory axis attenuates physiological reactions to emotional stress.

Conclusions:

  • The angiotensin-(1-7)/Mas axis represents a potential therapeutic target.
  • Modulating this axis may help reduce the physiological impact of emotional stress.
  • Targeting the angiotensin-(1-7)/Mas axis could lower the risk of cardiovascular diseases associated with stress.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
8.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
664